These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23137765)

  • 1. Achievement of therapeutic targets in Mexican patients with diabetes mellitus.
    Lavalle-González FJ; Chiquete E; de la Luz J; Ochoa-Guzmán A; Sánchez-Orozco LV; Godínez-Gutiérrez SA;
    Endocrinol Nutr; 2012 Dec; 59(10):591-8. PubMed ID: 23137765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoprotein subspecies between patients with type 1 diabetes and type 2 diabetes without / with intensive insulin therapy.
    Fukui T; Hirano T
    Endocr J; 2012; 59(7):561-9. PubMed ID: 22504174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter international registry to evaluate the clinical practice delivered to patients with type 2 diabetes mellitus: a sub-analysis of the experience in Mexico].
    Fanghänel Salmón G; Sánchez-Reyes L; Chiquete Anaya E; de la Luz Castro J; Escalante Herrera A
    Gac Med Mex; 2011; 147(3):226-33. PubMed ID: 21743590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing quality care for children and adolescents with diabetes from lower-income families in Mexico.
    Mota-Oropeza ME; Bartley HE; Hernández-Pérez ND; Lara AG; Vázquez-López NA; Flores MF; Velázquez MM; Castañeda-Saldivar MJ; Middlehurst AC; Jenkins AJ; Ogle GD
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1139-1146. PubMed ID: 31483761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with therapeutic target achievement in the control of complications in consequence of diabetes: A hospital-based study in west of Iran.
    Barzkar H; Nikbakht HA; Zeinolabedini M; Babazadeh T; Hassanipour S; Ghaffari-Fam S
    Diabetes Metab Syndr; 2019; 13(3):2009-2013. PubMed ID: 31235128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 1 diabetes management: Room for improvement.
    Varkevisser RDM; Birnie E; Mul D; van Dijk PR; Aanstoot HJ; Wolffenbuttel BHR; van der Klauw MM
    J Diabetes; 2023 Mar; 15(3):255-263. PubMed ID: 36808864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
    Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
    Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Scand J Prim Health Care; 2016 Sep; 34(3):267-73. PubMed ID: 27404014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes.
    Canas JA; Ross JL; Taboada MV; Sikes KM; Damaso LC; Hossain J; Caulfield MP; Gidding SS; Mauras N
    Pediatr Diabetes; 2015 Mar; 16(2):79-89. PubMed ID: 25418907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does rapid transition to insulin therapy in subjects with newly diagnosed type 2 diabetes mellitus benefit glycaemic control and diabetes-related complications? A German population-based study.
    Simons WR; Vinod HD; Gerber RA; Bolinder B
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):520-6. PubMed ID: 17115350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey).
    Andel M; Grzeszczak W; Michalek J; Medvescek M; Norkus A; Rasa I; Niewada M; Kamiński B; Kraml P; Madacsy L;
    Diabet Med; 2008 Oct; 25(10):1195-203. PubMed ID: 19046198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is insulin the preferred treatment for HbA1c >9%?
    Bloomgarden Z
    J Diabetes; 2017 Sep; 9(9):814-816. PubMed ID: 28589542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
    Boytsov S; Logunova N; Khomitskaya Y;
    Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain.
    Enes P; Martín-Frías M; Álvarez MÁ; Yelmo R; Alonso M; Barrio R
    Diabetes Res Clin Pract; 2015 Feb; 107(2):300-5. PubMed ID: 25595220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.